D-0003-2021 Class II Terminated

Recalled by Teva Pharmaceuticals USA — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
October 7, 2020
Initiation Date
September 4, 2020
Termination Date
August 26, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
32,543 cartons

Product Description

Buprenorphine Transdermal System 5 mcg/hour, 4 transdermal systems/4 disposal units per carton, Rx Only, Manufactured by: 3M Drug Delivery Systems, 19901 Nordhoff street, Northridge, CA 91324 USA, Manufactured for: Teva Pharmaceuticals USA Inc., North Wales, PA 19454, carton NDC: 0093-3656-40, patch NDC: 0093-3656-21.

Reason for Recall

Failed Stability Specifications: Below specification result for buprenorphine release rate.

Distribution Pattern

Nationwide in the U.S. and PR

Code Information

Lot # 190017, exp. 02/2021; 190161, exp. 08/2021